Screening for a rare lymphoma type in eye inflammation patients
Treatments studied
Part of Blood & lymphatic, Cancer, Eyes & vision, Immune system & allergy clinical trials.
This trial screens people with certain eye inflammation (uveitis) to see if they might have a specific rare lymphoma linked to immune cells. It may help doctors identify the right diagnosis and understand which patients need closer monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You must be able to sign informed consent before any study procedures
- You have a specific eye condition: uveitis in one or both eyes, or a related eye issue that fits their listed groups (for example, primary eye lymphoma with or without brain involvement, or certain eye problems without uveitis)
- You do not have an unclear diagnosis—your eye/brain lymphoma status must be certain enough for screening
- You are not currently in another clinical trial
- You cannot be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study creates a registry for people with certain T-cell or NK-cell lymphomas. It collects health information and tumor samples to learn more about these diseases and improve future treatments.
This trial uses a new genetic test to find the cause of eye inflammation when standard tests haven't. The goal is to see if this approach can identify hidden infections and help doctors choose the right treatment to protect your vision.
This study collects immune cells (from a blood sample) from people with certain types of age-related macular degeneration (AMD) and compares how long they live. It may help researchers understand how immune-related changes relate to AMD outcomes.
This study looks at “biomarkers” (measurable signs in your tumor and possibly blood) to understand your lymphoma’s genetic make-up. The goal is to see which markers may help doctors decide on treatment and timing.
This study looks for biological markers in the blood or eye samples of people with rare eye diseases compared to healthy volunteers. It aims to better understand and diagnose these conditions.
This trial is a general screening step for people who may have an eye (ocular) condition, or for family members of someone with an eye condition. The goal is to help match you to an eye research study by confirming your situation and whether you can safely participate.
Hear when a new Uveitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.